Stryker must face Trident hip implant lawsuit

Stryker Corp.

Stryker (NYSE:SYK) can’t slip a personal injury lawsuit filed over its Trident hip implant because the case asserts a "parallel" claim that isn’t preempted by federal law, a federal judge in Massachusetts ruled this week.

Raymond Chasse Jr. and Stephen Miele sued Kalamazoo, Mich.-based Stryker in December 2012 in the U.S. District Court for Massachusetts, alleging that the medical device company was negligent in its manufacture and distribution of the Trident hip replacement system, according to court documents.

Stryker moved to dismiss the case, arguing that it is preempted by federal law, but Judge Patty Saris disagreed, dismissing the Stryker motion on the grounds that the case parallels but does not add to federal regulation of medical devices.

Chasse and Miele argued that Stryker was negligent under Massachusetts law, including Current Good Manufacturing Practice regulations. Saris cited prior appeals court decisions that allowed CGMP regulations to serve as parallel claims.

"The two Circuits to have addressed the precise issue have rejected efforts to dismiss substantially similar common law claims against Stryker, holding that CGMPs are ‘legally binding requirements’ that can serve as the basis of a ‘parallel’ claim when they are alleged to have caused the plaintiff’s specific injury," Saris wrote, according to court documents.

Chasse and Miele brought the purported class action lawsuit on behalf of all Massachusetts residents who "have undergone total hip arthroplasty since 2003 using the defendants’ Trident System containing Trident Hemispherical Acetabular Shells, and who have experienced a failure of said Trident System as evidenced by the following: an audible ‘squeaking’ emanating from the replaced hip joint area; pain and/or discomfort in the replaced hip joint area; and/or the necessity for revision surgery of the replaced hip joint," according to court documents.

Miele’s double hip replacement in May 2004, according to the documents, with Chasse undergoing a left hip replacement in 2005. Stryker recalled the Trident devices in January 2008 after an investigation found "deviations between specifications and processes for manufacturing required by the FDA whereby, among other failures, excessive bioburden and manufacturing residuals were found in the final rinse tank thereby contaminating the devices," according to the lawsuit.

Miele began experiencing discomfort and pain in February 2010 and eventually had revision surgeries for both hips in 2012, according to the documents.

"The Trident Systems implanted into plaintiff Miele failed and became ‘grossly loose’ because bone ingrowth was inhibited on plaintiff Miele’s devices due to contamination as a result of defendants’ failure to comply with the FDA’s standards and requirements established and approved through the PMA process for the Trident system," according to the complaint.

For Chasse the trouble allegedly began in January 2012 and also led to a revision surgery in August of that year, according to the lawsuit.

"The Trident System implanted into plaintiff Chasse failed and exhibited striping and improper wear marks due to dimensional mismatching caused by defendants’ failure to comply with the FDA’s standards and requirements established and approved through the PMA process for the Trident system," the complaint states.

RSS From Medical Design & Outsourcing

  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]
  • Cosasco’s wireless communications protocol makes electrically hazardous areas safer
    Cosasco has expanded the functionality of its CWT-9020 wireless water system corrosion monitor for electrically hazardous areas by offering ISA100 Wireless communications protocol. Along with WirelessHART 7, the new protocol option allows the transmitter to integrate with an even wider range of existing wireless systems. ISA100 Wireless supports more wireless devices and provides an effective […]
  • Vicon captures a new development in motion capture (mocap)
    Vicon announced the launch of its new flagship camera platform, the Vicon Vantage. Drawing on over 30 years’ of motion capture (mocap) experience, the Vantage platform combines innovative technology with accessible design to open up motion capture to a broader audience. Vicon is a motion capture technology specialist company for science and life industries. Advances in […]
  • Satel’s latest product sets a new milestone in radio manufacturing
    The new Satelline TR4, from the Finnish manufacturer of radio data transmission systems, Satel sets a new milestone. The compact UHF transceiver with transmitting power of 1,000 mW is compatible with the protocols of Pacific Crest, Trimble and Satel. The type certifications in all important regions of the world make the TR4 ideal for integration […]
  • SCHURTER announces retirement of founder and management changes
    SCHURTER announced the retirement of founder Bruno H. Schurter on June 29, 2015. The company, founded in 1982 in Petaluma, California, will change management effective July 1, 2015. Bruno H. Schurter, president and CEO will retire after 33 years of heading up the privately held company, which is a subsidiary of SCHURTER Holding AG, founded in […]
  • Silicone: Expanding the horizon for modern medical devices
    Editor’s note: This article comes from Albright Technologies a manufacturer of custom silicone prototypes and provides volume production for medical, pharmaceutical, industrial, and other applications. Silicone materials have been around for more than 70 years. Beginning in the 1960s, silicones have played an important and evolving part in products designed for the medical field. Since that time, […]
  • DeNovo Sciences appoints a molecular diagnostics veteran as new CSO
    DeNovo Sciences, a producer of  liquid biopsy products, announced the appointment of Dr. Yixin Wang as Chief Scientific Officer (CSO). Dr. Wang is a veteran in molecular diagnostics where he has played significant R&D roles at large, multi-national companies including Parke-Davis/Pfizer, Veridex/Johnson & Johnson and Ventana/Roche. He will lead strategic initiatives for clinical development of DeNovo’s […]
  • Albright Technologies expands their silicone offerings
    Albright Technologies, a rapid silicone prototyper, has added silicone injection molding tooling and services to its product lineup. Liquid silicone injection molding became a suitable product offering as Albright expanded its offerings to better serve the silicone molding market. While silicone prototypes are commonly manufactured with low volumes in mind; injection molded liquid silicone rubber parts are […]
  • Applied Silver launches SilvaClean, silver treatment for textiles
    Applied Silver, Inc, is launching SilvaClean, a state-of-the-art silver treatment for textiles, at the Association for Professionals in Infection Control and Epidemiology’s (APIC) forty-second Annual Conference taking place at the Music City Center in Nashville, from June 27 through June 29. Hospitals have invested significantly in reducing the potential of infection through products and processes designed […]
  • Two-Component technology for improved quality of life
    In the field of injection molding and mold making, toolcraft covers all processes within the added value chain–from the design and selection of materials through to the creation of finished and qualified products. Complete solutions offered include injection molding for parts in the small and extremely small component areas, e.g. for medical technology. Utilizing two-component […]

Leave a Reply